11-166
Showing 1 - 25 of 6,895
Liver Metastases, Breast Cancer Trial in Leuven, Amsterdam (Quiremspheres™)
Recruiting
- Liver Metastases
- Breast Cancer
- Quiremspheres™
-
Leuven, Vlaams-Brabant, Belgium
- +1 more
Nov 16, 2023
Hepatocellular Carcinoma Trial (Holmium-166 treatment, Holmium-166 work-up)
Not yet recruiting
- Hepatocellular Carcinoma
- Holmium-166 treatment
- Holmium-166 work-up
- (no location specified)
Jul 6, 2022
Hepatocellular Carcinoma Trial in Brussels (Radioembolization using Holmium-166)
Active, not recruiting
- Hepatocellular Carcinoma
- Radioembolization using Holmium-166
-
Brussels, Anderlecht, BelgiumHôpital Universitaire Erasme, ULB
Dec 7, 2022
Amyotrophic Lateral Sclerosis Trial in Charlotte (Placebo (for MN-166), MN-166, riluzole)
Completed
- Amyotrophic Lateral Sclerosis
- Placebo (for MN-166)
- +2 more
-
Charlotte, North CarolinaCarolinas Healthcare System, Dept. of Neurology
Oct 7, 2021
Glioblastoma, Recurrent Glioblastoma, GBM Trial in Boston (MN-166, Temozolomide)
Active, not recruiting
- Glioblastoma
- +3 more
-
Boston, MassachusettsDana-Farber Cancer Institute
Nov 16, 2022
Osteoarthritis Trial in Worldwide (LNA043 Dosing Regimen A, LNA043 Dosing Regimen B, LNA043 Dosing Regimen C)
Recruiting
- Osteoarthritis
- LNA043 Dosing Regimen A
- +4 more
-
Phoenix, Arizona
- +107 more
Nov 4, 2022
Holmium-166 Retrospective Collection of Real-World Data
Completed
- Hepatocellular Carcinoma
- Metastatic Cancer
- Selective Internal Radiation Therapy with QuiremSpheresTM Holmium-166 Microspheres
-
Aalst, Belgium
- +11 more
Aug 29, 2022
Pancreas Cancer Trial in Nijmegen (Intratumoral)
Recruiting
- Pancreas Cancer
- Intratumoral
-
Nijmegen, Gelderland, NetherlandsRadboud University Medical Centre
May 19, 2023
Acute Myocardial Infarction, Heart Failure Trial in Sweden, United Kingdom (Dapagliflozin, Placebo)
Recruiting
- Acute Myocardial Infarction
- Heart Failure
- Dapagliflozin
- Placebo
-
Alingsås, Sweden
- +112 more
Aug 18, 2022
Renal Transplantation Trial in Worldwide (sotrastaurin (Dose 1) + tacrolimus + standard of care medications, sotrastaurin (Dose
Completed
- Renal Transplantation
- sotrastaurin (Dose 1) + tacrolimus + standard of care medications
- +3 more
-
Birmingham, Alabama
- +43 more
Dec 15, 2020
Primary Liver Cancer, Non-Resectable Hepatocellular Carcinoma Trial (MRI-guided radioembolization)
Not yet recruiting
- Primary Liver Cancer
- Non-Resectable Hepatocellular Carcinoma
- MRI-guided radioembolization
- (no location specified)
Nov 1, 2022
QTc Intervals in Former Preterm/Extreme Low Birth Weight
Enrolling by invitation
- Qt Interval
- Preterm Birth
- ECG (diagnostic)
-
Leuven, Belgium
- +1 more
Jul 7, 2022
Hepatocellular Carcinoma Trial in France (QuiremSpheres)
Recruiting
- Hepatocellular Carcinoma
- QuiremSpheres
-
Clichy, France
- +3 more
Jan 27, 2023
Esophageal Cancer, Gastric Cancer Trial in United States (Afatinib and Paclitaxel)
Active, not recruiting
- Esophageal Cancer
- Gastric Cancer
- Afatinib and Paclitaxel
-
Los Angeles, California
- +8 more
Mar 18, 2022
Paroxysmal Atrial Fibrillation Trial in Guangzhou (Pulse ablation catheter)
Active, not recruiting
- Paroxysmal Atrial Fibrillation
- Pulse ablation catheter
-
Guangzhou, Guangdong, Chinathe Second Affiliated Hospital of Sun Yat-sen University (Sun Ya
Sep 10, 2023
Dry Eye Disease Trial in United States (CyclASol topical ocular, eye drops, Vehicle topical ocular, eye drops)
Completed
- Dry Eye Disease
- CyclASol topical ocular, eye drops
- Vehicle topical ocular, eye drops
-
Newport Beach, California
- +8 more
Dec 21, 2022
Delinquency, Drug Use Trial in Eugene (Treatment Foster Care (TFCO), Group Care)
Completed
- Delinquency
- Drug Use
- Treatment Foster Care (TFCO)
- Group Care
-
Eugene, Oregon
- +1 more
Feb 23, 2022
Renal Cell Carcinoma Trial in Worldwide (Cabozantinib, Nivolumab, Ipilimumab)
Active, not recruiting
- Renal Cell Carcinoma
- Cabozantinib
- +3 more
-
La Jolla, California
- +159 more
Jan 23, 2023
Systemic Lupus Erythematosus Trial in Worldwide (BENLYSTA, SLE treatment)
Active, not recruiting
- Systemic Lupus Erythematosus
- BENLYSTA
- SLE treatment
-
Birmingham, Alabama
- +177 more
Jan 23, 2023
Identify Barriers to Cellular Therapies for People With Plasma
Recruiting
- Multiple Myeloma
- Lecture on the role of cellular therapies in relapse/refractory multiple myeloma/RRMM
- +5 more
-
Basking Ridge, New Jersey
- +6 more
Nov 6, 2023
Netherton Syndrome Trial in San Diego, San Antonio (QRX003, 4% Lotion)
Recruiting
- Netherton Syndrome
- QRX003, 4% Lotion
-
San Diego, California
- +1 more
Mar 28, 2023
Serum Magnesium Level in Type 2 Diabetes Mellitus
Not yet recruiting
- Diabetes Mellitus
- Magnesium
-
Sohag, EgyptSohag university Hospital
Sep 22, 2023